Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: Antibiotics

HEALTH-CORONAVIRUS/FRANCE-CHLOROQUINE
RTS3FLYL
June 24, 2020
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial...
Paris, France
Hearing of French medicine professor Didier Raoult
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial drug, and azithromycin, a common antibiotic, as a remedy for the coronavirus disease (COVID-19), wears a protective face mask as he arrives to attend a hearing at the National Assembly in Paris, France, June 24, 2020. At R, Member of Parliament Eric Ciotti. REUTERS/Gonzalo Fuentes
HEALTH-CORONAVIRUS/FRANCE-CHLOROQUINE
RTS3FLX1
June 24, 2020
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial...
Paris, France
Hearing of French medicine professor Didier Raoult
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial drug, and azithromycin, a common antibiotic, as a remedy for the coronavirus disease (COVID-19), is surrounded by journalists as he arrives to attend a hearing at the National Assembly in Paris, France, June 24, 2020. REUTERS/Gonzalo Fuentes
HEALTH-CORONAVIRUS/FRANCE-CHLOROQUINE
RTS3FLWO
June 24, 2020
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial...
Paris, France
Hearing of French medicine professor Didier Raoult
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial drug, and azithromycin, a common antibiotic, as a remedy for the coronavirus disease (COVID-19), arrives to attend a hearing at the National Assembly in Paris, France, June 24, 2020. REUTERS/Gonzalo Fuentes
HEALTH-CORONAVIRUS/FRANCE-CHLOROQUINE
RTS3FLWK
June 24, 2020
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial...
Paris, France
Hearing of French medicine professor Didier Raoult
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial drug, and azithromycin, a common antibiotic, as a remedy for the coronavirus disease (COVID-19), arrives to attend a hearing at the National Assembly in Paris, France, June 24, 2020. REUTERS/Gonzalo Fuentes
HEALTH-CORONAVIRUS/FRANCE-CHLOROQUINE
RTS3FLWI
June 24, 2020
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial...
Paris, France
Hearing of French medicine professor Didier Raoult
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial drug, and azithromycin, a common antibiotic, as a remedy for the coronavirus disease (COVID-19), arrives to attend a hearing at the National Assembly in Paris, France, June 24, 2020. REUTERS/Gonzalo Fuentes
HEALTH-CORONAVIRUS/FRANCE-CHLOROQUINE
RTS3FLWH
June 24, 2020
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial...
Paris, France
Hearing of French medicine professor Didier Raoult
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial drug, and azithromycin, a common antibiotic, as a remedy for the coronavirus disease (COVID-19), arrives to attend a hearing at the National Assembly in Paris, France, June 24, 2020. REUTERS/Gonzalo Fuentes
HEALTH-CORONAVIRUS/FRANCE-CHLOROQUINE
RTS3FLW5
June 24, 2020
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial...
Paris, France
Hearing of French medicine professor Didier Raoult
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial drug, and azithromycin, a common antibiotic, as a remedy for the coronavirus disease (COVID-19), is surrounded by journalists as he arrives to attend a hearing at the National Assembly in Paris, France, June 24, 2020. REUTERS/Gonzalo Fuentes
HEALTH-CORONAVIRUS/FRANCE-CHLOROQUINE
RTS3FLTS
June 24, 2020
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial...
Paris, France
Hearing of French medicine professor Didier Raoult
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial drug, and azithromycin, a common antibiotic, as a remedy for the coronavirus disease (COVID-19), is surrounded by journalists as he arrives to attend a hearing at the National Assembly in Paris, France, June 24, 2020. REUTERS/Gonzalo Fuentes
HEALTH-CORONAVIRUS/FRANCE-CHLOROQUINE
RTS3FLTR
June 24, 2020
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial...
Paris, France
Hearing of French medicine professor Didier Raoult
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial drug, and azithromycin, a common antibiotic, as a remedy for the coronavirus disease (COVID-19), arrives to attend a hearing at the National Assembly in Paris, France, June 24, 2020. REUTERS/Gonzalo Fuentes
HEALTH-CORONAVIRUS/FRANCE-CHLOROQUINE
RTS3FLTF
June 24, 2020
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial...
Paris, France
Hearing of French medicine professor Didier Raoult
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial drug, and azithromycin, a common antibiotic, as a remedy for the coronavirus disease (COVID-19), is surrounded by journalists as he arrives to attend a hearing at the National Assembly in Paris, France, June 24, 2020. REUTERS/Gonzalo Fuentes
HEALTH-CORONAVIRUS/FRANCE-CHLOROQUINE
RTS3FLT8
June 24, 2020
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial...
Paris, France
Hearing of French medicine professor Didier Raoult
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial drug, and azithromycin, a common antibiotic, as a remedy for the coronavirus disease (COVID-19), wears a protective face mask as he arrives to attend a hearing at the National Assembly in Paris, France, June 24, 2020. At R, Member of Parliament Eric Ciotti. REUTERS/Gonzalo Fuentes
HEALTH-CORONAVIRUS/FRANCE-CHLOROQUINE
RTS3FLT2
June 24, 2020
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial...
Paris, France
Hearing of French medicine professor Didier Raoult
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial drug, and azithromycin, a common antibiotic, as a remedy for the coronavirus disease (COVID-19), wears a protective face mask as he arrives to attend a hearing at the National Assembly in Paris, France, June 24, 2020. At R, Member of Parliament Eric Ciotti. REUTERS/Gonzalo Fuentes
HEALTH-CORONAVIRUS/FRANCE-CHLOROQUINE
RTS3FLST
June 24, 2020
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial...
Paris, France
Hearing of French medicine professor Didier Raoult
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial drug, and azithromycin, a common antibiotic, as a remedy for the coronavirus disease (COVID-19), wears a protective face mask as he arrives to attend a hearing at the National Assembly in Paris, France, June 24, 2020. At R, Member of Parliament Eric Ciotti. REUTERS/Gonzalo Fuentes
HEALTH-CORONAVIRUS/FRANCE-CHLOROQUINE
RTS3FLSP
June 24, 2020
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial...
Paris, France
Hearing of French medicine professor Didier Raoult
French medicine professor Didier Raoult, who has promoted a combination of hydroxychloroquine, an antimalarial drug, and azithromycin, a common antibiotic, as a remedy for the coronavirus disease (COVID-19), wears a protective face mask as he arrives to attend a hearing at the National Assembly in Paris, France, June 24, 2020. At R, Member of Parliament Eric Ciotti. REUTERS/Gonzalo Fuentes
KENYA-RHINOS/
RTS31NM8
February 11, 2020
PhD student Collins Kipkorir Kebeni points to data comparing human and rhino antibiotics resistance on...
MASENO, Kenya
PhD student Collins Kipkorir Kebeni points to data comparing human and rhino antibiotics resistance on...
PhD student Collins Kipkorir Kebeni points to data comparing human and rhino antibiotics resistance on a computer at the Zoology lab of the Maseno University, in Maseno, western Kenya, January 30, 2020. Picture taken January 30, 2020. REUTERS/Baz Ratner
ENVIRONMENT-CORALS/SCIENTISTS
RTX75TB5
October 02, 2019
Marilyn Brandt, a research associate professor at the University of the Virgin Islands' Center for Marine...
Charlotte Amalie, UNITED STATES VIRGIN ISLANDS
Marilyn Brandt, a research associate professor at the University of the Virgin Islands' Center for Marine...
Marilyn Brandt, a research associate professor at the University of the Virgin Islands' Center for Marine and Environmental Studies, applies an antibiotic paste to corals being killed by Stony Coral Tissue Loss Disease (SCTLD) near the University of the Virgin Islands campus in St Thomas in the U.S. Virgin Islands, May 14, 2019. REUTERS/Lucas Jackson
ENVIRONMENT-CORALS/SCIENTISTS
RTX75TAQ
October 02, 2019
Kevin Macaulay combines antibiotic powder with a paste in preparation for a dive to apply antibiotic...
Key West, UNITED STATES
Kevin Macaulay combines antibiotic powder with a paste in preparation for a dive to apply antibiotic...
Kevin Macaulay combines antibiotic powder with a paste in preparation for a dive to apply antibiotic ointment to corals afflicted by Stony Tissue Loss Disease (SCTLD) near Key West, Florida, U.S. September 8, 2019. REUTERS/Lucas Jackson
ENVIRONMENT-CORALS/SCIENTISTS
RTX75TAH
October 02, 2019
Emily Hower holds her mask as she enters the water for a dive to apply antibiotic ointment to corals...
Key West, UNITED STATES
Emily Hower holds her mask as she enters the water for a dive to apply antibiotic ointment to corals...
Emily Hower holds her mask as she enters the water for a dive to apply antibiotic ointment to corals afflicted by Stony Tissue Loss Disease (SCTLD) near Key West, Florida, U.S. September 8, 2019. REUTERS/Lucas Jackson
ENVIRONMENT-CORALS/SCIENTISTS
RTX75TAC
October 02, 2019
Kevin Macaulay cleans himself with fresh water after a dive to apply antibiotic ointment to corals afflicted...
Key West, UNITED STATES
Kevin Macaulay cleans himself with fresh water after a dive to apply antibiotic ointment to corals afflicted...
Kevin Macaulay cleans himself with fresh water after a dive to apply antibiotic ointment to corals afflicted by Stony Tissue Loss Disease (SCTLD) near Key West, Florida, U.S. September 8, 2019. REUTERS/Lucas Jackson
ENVIRONMENT-CORALS/SCIENTISTS
RTX75TA5
October 02, 2019
Emily Hower applies a topical antibiotic ointment to a large coral colony to slow the spread of Stony...
Key West, UNITED STATES
Emily Hower applies a topical antibiotic ointment to a large coral colony to slow the spread of Stony...
Emily Hower applies a topical antibiotic ointment to a large coral colony to slow the spread of Stony Tissue Loss Disease (SCTLD) on a dive near Key West, Florida, U.S. September 8, 2019. REUTERS/Lucas Jackson
ENVIRONMENT-CORALS/SCIENTISTS
RTX75TA1
October 02, 2019
Kevin Macaulay applies a topical antibiotic ointment to a large coral colony to slow the spread of Stony...
Key West, UNITED STATES
Kevin Macaulay applies a topical antibiotic ointment to a large coral colony to slow the spread of Stony...
Kevin Macaulay applies a topical antibiotic ointment to a large coral colony to slow the spread of Stony Tissue Loss Disease (SCTLD) on a dive near Key West, Florida, U.S. September 8, 2019. REUTERS/Lucas Jackson
ENVIRONMENT-CORALS/SCIENTISTS
RTX75T9Y
October 02, 2019
A nail is used to mark the extent of tissue killed by Stony Tissue Loss Disease (SCTLD) underneath an...
Key West, UNITED STATES
A nail is used to mark the extent of tissue killed by Stony Tissue Loss Disease (SCTLD) underneath an...
A nail is used to mark the extent of tissue killed by Stony Tissue Loss Disease (SCTLD) underneath an antibiotic ointment applied to a large Orbicella faveolata (Mountainous Star Coral) colony on a dive near Key West, Florida, U.S. September 8, 2019. REUTERS/Lucas Jackson
ENVIRONMENT-CORALS/SCIENTISTS
RTX75T9W
October 02, 2019
Kevin Macaulay prepares to mark a coral after applying a topical antibiotic ointment to slow the spread...
Key West, UNITED STATES
Kevin Macaulay prepares to mark a coral after applying a topical antibiotic ointment to slow the spread...
Kevin Macaulay prepares to mark a coral after applying a topical antibiotic ointment to slow the spread of Stony Tissue Loss Disease (SCTLD) on a dive near Key West, Florida, U.S. September 8, 2019. REUTERS/Lucas Jackson
ENVIRONMENT-CORALS/SCIENTISTS
RTX75T91
October 02, 2019
Kevin Macaulay applies an antibiotic ointment to the surface of an Orbicella Faveolata (Mountainous Star...
Kevin Macaulay applies an antibiotic ointment to the surface of an Orbicella Faveolata (Mountainous Star...
Kevin Macaulay applies an antibiotic ointment to the surface of an Orbicella Faveolata (Mountainous Star Coral) affected by Stony Tissue Loss Disease (SCTLD) on a dive near Key West, Florida, U.S. September 8, 2019. REUTERS/Lucas Jackson
ENVIRONMENT-CORALS/SCIENTISTS
RTX75T7V
October 02, 2019
Karen Neely, a coral ecologist at Nova Southeastern University, enters the water for a dive to apply...
Key West, UNITED STATES
Karen Neely, a coral ecologist at Nova Southeastern University, enters the water for a dive to apply...
Karen Neely, a coral ecologist at Nova Southeastern University, enters the water for a dive to apply antibiotic ointment to corals afflicted by Stony Tissue Loss Disease (SCTLD) near Key West, Florida, U.S. September 8, 2019. REUTERS/Lucas Jackson
ENVIRONMENT-CORALS/SCIENTISTS
RTX74QOD
September 26, 2019
Marilyn Brandt, a research associate professor at the University of the Virgin Islands' Center for Marine...
Charlotte Amalie, UNITED STATES VIRGIN ISLANDS
The Wider Image: The race to save the coral of the Caribbean
Marilyn Brandt, a research associate professor at the University of the Virgin Islands' Center for Marine and Environmental Studies, applies an antibiotic paste to corals being killed by Stony Coral Tissue Loss Disease (SCTLD) near the University of the Virgin Islands campus in St Thomas in the U.S. Virgin Islands, May 14, 2019. REUTERS/Lucas Jackson SEARCH "JACKSON CORAL" FOR THIS STORY. SEARCH "WIDER IMAGE" FOR ALL STORIES.
ENVIRONMENT-CORALS/SCIENTISTS
RTX74QND
September 26, 2019
Kevin Macaulay, research assistant at Nova Southeastern University, applies an antibiotic ointment to...
Key West, UNITED STATES
The Wider Image: The race to save the coral of the Caribbean
Kevin Macaulay, research assistant at Nova Southeastern University, applies an antibiotic ointment to the surface of a coral to slow the spread of Stony Tissue Loss Disease (SCTLD) while on a dive near Key West, Florida, U.S. September 8, 2019. REUTERS/Lucas Jackson SEARCH "JACKSON CORAL" FOR THIS STORY. SEARCH "WIDER IMAGE" FOR ALL STORIES. TPX IMAGES OF THE DAY.
ENVIRONMENT-CORALS/SCIENTISTS
RTX74QN9
September 26, 2019
A nail is used to mark the extent of tissue killed by Stony Tissue Loss Disease (SCTLD) underneath an...
Key West, UNITED STATES
The Wider Image: The race to save the coral of the Caribbean
A nail is used to mark the extent of tissue killed by Stony Tissue Loss Disease (SCTLD) underneath an antibiotic ointment applied to a large Orbicella faveolata (Mountainous Star Coral) colony on a dive near Key West, Florida, U.S. September 8, 2019. REUTERS/Lucas Jackson SEARCH "JACKSON CORAL" FOR THIS STORY. SEARCH "WIDER IMAGE" FOR ALL STORIES.
ENVIRONMENT-CORALS/SCIENTISTS
RTX74QN7
September 26, 2019
Kevin Macaulay, research assistant at Nova Southeastern University, holds his mask as he enters the water...
Key West, UNITED STATES
The Wider Image: The race to save the coral of the Caribbean
Kevin Macaulay, research assistant at Nova Southeastern University, holds his mask as he enters the water for a dive to apply antibiotic ointment to corals afflicted by Stony Tissue Loss Disease (SCTLD) near Key West, Florida, U.S. September 8, 2019. REUTERS/Lucas Jackson SEARCH "JACKSON CORAL" FOR THIS STORY. SEARCH "WIDER IMAGE" FOR ALL STORIES.
ENVIRONMENT-CORALS/SCIENTISTS
RTX74QN3
September 26, 2019
Kevin Macaulay, research assistant at Nova Southeastern University, applies an antibiotic ointment to...
Key West, UNITED STATES
The Wider Image: The race to save the coral of the Caribbean
Kevin Macaulay, research assistant at Nova Southeastern University, applies an antibiotic ointment to the surface of an Orbicella faveolata (Mountainous Star Coral) affected by Stony Tissue Loss Disease (SCTLD) on a dive near Key West, Florida, U.S. September 8, 2019. REUTERS/Lucas Jackson SEARCH "JACKSON CORAL" FOR THIS STORY. SEARCH "WIDER IMAGE" FOR ALL STORIES. TPX IMAGES OF THE DAY.
ENVIRONMENT-CORALS/SCIENTISTS
RTX74QMO
September 26, 2019
Emily Hower cleans her mask as she prepares to enter the water for a dive to apply antibiotic ointment...
Key West, UNITED STATES
The Wider Image: The race to save the coral of the Caribbean
Emily Hower cleans her mask as she prepares to enter the water for a dive to apply antibiotic ointment to corals afflicted by Stony Tissue Loss Disease (SCTLD) near Key West, Florida, U.S. September 8, 2019. REUTERS/Lucas Jackson SEARCH "JACKSON CORAL" FOR THIS STORY. SEARCH "WIDER IMAGE" FOR ALL STORIES.
CHINA-SWINEFEVER/FARMERS
RTS2D7BZ
February 01, 2019
Pig farmer Han Yi prepares antibiotic shots for his pigs on his farm at a village in Changtu county,...
CHANGTU, China
Pig farmer Han Yi prepares antibiotic shots for his pigs on his farm at a village in Changtu
Pig farmer Han Yi prepares antibiotic shots for his pigs on his farm at a village in Changtu county, Liaoning province, China January 17, 2019. Picture taken January 17, 2019. REUTERS/Ryan Woo
GLOBAL-PHARMA/
RTX670YE
May 31, 2018
Ten pills of the antibiotic "Amoxicillin 1000mg" are seen at a pharmacy in Hanau, Germany, May 31, 2018....
Hanau, Germany
Ten pills of the antibiotic "Amoxicillin 1000mg" are seen at a pharmacy in Hanau
Ten pills of the antibiotic "Amoxicillin 1000mg" are seen at a pharmacy in Hanau, Germany, May 31, 2018. REUTERS/Kai Pfaffenbach
VENEZUELA-SHORTAGES/HOSPITALS
RTX5RT59
April 17, 2018
Workers of the health sector take part in a protest due to the shortages of basic medical supplies and...
Caracas, Venezuela
Workers of the health sector take part in a protest, due to the shortages of basic medical supplies and...
Workers of the health sector take part in a protest due to the shortages of basic medical supplies and for higher wages outside a children hospital in Caracas, Venezuela April 17, 2018. The placard reads, "Rights to medicines. Antibiotics". REUTERS/Carlos Garcia Rawlins
HEALTH-ANTIBIOTICS/
RTS1LYJT
January 31, 2018
Juan Lubroth, Food and Agriculture Organization's Chief Veterinary Officer of the UN, poses during an...
Bangkok, Thailand
Juan Lubroth, Food and Agriculture Organization's Chief Veterinary Officer of the UN, poses during an...
Juan Lubroth, Food and Agriculture Organization's Chief Veterinary Officer of the UN, poses during an interview with Reuters in Bangkok, Thailand January 31, 2018. REUTERS/Amy Sawitta Lefevre
YUM- BRANDS-KFC/ANTIBIOTICS
RTX34IB9
April 07, 2017
A Kentucky Fried Chicken (KFC) plate of mixed fried and grilled chicken with a biscuit and coleslaw is...
New York, UNITED STATES
A Kentucky Fried Chicken (KFC) plate of mixed fried and grilled chicken with a biscuit and coleslaw is...
A Kentucky Fried Chicken (KFC) plate of mixed fried and grilled chicken with a biscuit and coleslaw is seen in this picture illustration taken April 6, 2017. REUTERS/Carlo Allegri
YUM- BRANDS-KFC/ANTIBIOTICS
RTX34IB7
April 07, 2017
Kentucky Fried Chicken (KFC) tenders are seen in this picture illustration taken April 6, 2017. REUTERS/Carlo...
New York, UNITED STATES
Kentucky Fried Chicken (KFC) tenders are seen in this picture illustration
Kentucky Fried Chicken (KFC) tenders are seen in this picture illustration taken April 6, 2017. REUTERS/Carlo Allegri
YUM- BRANDS-KFC/ANTIBIOTICS
RTX34IB5
April 07, 2017
A Kentucky Fried Chicken (KFC) bucket of fried chicken is seen in this picture illustration taken April...
New York, UNITED STATES
A Kentucky Fried Chicken (KFC) bucket of fried chicken is seen in this picture illustration
A Kentucky Fried Chicken (KFC) bucket of fried chicken is seen in this picture illustration taken April 6, 2017. REUTERS/Carlo Allegri
YUM- BRANDS-KFC/ANTIBIOTICS
RTX34IB4
April 07, 2017
A Kentucky Fried Chicken (KFC) bucket of fried chicken is seen in this picture illustration taken April...
New York, UNITED STATES
A Kentucky Fried Chicken (KFC) bucket of fried chicken is seen in this picture illustration
A Kentucky Fried Chicken (KFC) bucket of fried chicken is seen in this picture illustration taken April 6, 2017. REUTERS/Carlo Allegri
YUM- BRANDS-KFC/ANTIBIOTICS
RTX34IB3
April 07, 2017
A Kentucky Fried Chicken (KFC) bucket of grilled chicken is seen in this picture illustration taken April...
New York, UNITED STATES
A Kentucky Fried Chicken (KFC) bucket of grilled chicken is seen in this picture illustration
A Kentucky Fried Chicken (KFC) bucket of grilled chicken is seen in this picture illustration taken April 6, 2017. REUTERS/Carlo Allegri
YUM- BRANDS-KFC/ANTIBIOTICS
RTX34IB2
April 07, 2017
A Kentucky Fried Chicken (KFC) bucket of mixed fried and grilled chicken is seen in this picture illustration...
New York, UNITED STATES
A Kentucky Fried Chicken (KFC) bucket of mixed fried and grilled chicken is seen in this picture illustration...
A Kentucky Fried Chicken (KFC) bucket of mixed fried and grilled chicken is seen in this picture illustration taken April 6, 2017. REUTERS/Carlo Allegri
YUM- BRANDS-KFC/ANTIBIOTICS
RTX34IB1
April 07, 2017
Kentucky Fried Chicken (KFC) tenders, a bucket and box of chicken are seen in this picture illustration...
New York, UNITED STATES
Kentucky Fried Chicken (KFC) tenders, a bucket and box of chicken are seen in this picture illustration...
Kentucky Fried Chicken (KFC) tenders, a bucket and box of chicken are seen in this picture illustration taken April 6, 2017. REUTERS/Carlo Allegri
YUM- BRANDS-KFC/ANTIBIOTICS
RTX34IAZ
April 07, 2017
A Kentucky Fried Chicken (KFC) logo is pictured on a sign in North Miami Beach, Florida, U.S. April 6,...
New York, UNITED STATES
A Kentucky Fried Chicken (KFC) logo is pictured on a sign in North Miami Beach
A Kentucky Fried Chicken (KFC) logo is pictured on a sign in North Miami Beach, Florida, U.S. April 6, 2017. REUTERS/Carlo Allegri
YUM- BRANDS-KFC/ANTIBIOTICS
RTX34IAY
April 07, 2017
A Kentucky Fried Chicken (KFC) logo is pictured in North Miami Beach, Florida, U.S. April 6, 2017. ...
New York, UNITED STATES
A Kentucky Fried Chicken (KFC) logo is pictured in North Miami Beach
A Kentucky Fried Chicken (KFC) logo is pictured in North Miami Beach, Florida, U.S. April 6, 2017. REUTERS/Carlo Allegri
TURKEY-PIGEONS/
RTX2YSAU
January 13, 2017
Vitamins and antibiotics for pigeons are seen on a stand for sale in a tea house where pigeon auctions...
Sanliurfa, Turkey
The Wider Image: Beauty, money and feathers
Vitamins and antibiotics for pigeons are seen on a stand for sale in a tea house where pigeon auctions take place in Sanliurfa, Turkey, December 10, 2016. REUTERS/Umit Bektas SEARCH "PIGEONS AUCTION" FOR THIS STORY. SEARCH "WIDER IMAGE" FOR ALL STORIES.
USA-UNCOUNTED/DRUGS
RTX2V6RZ
December 15, 2016
Amy Spoering, Director of Biological Research at the biotech NovoBiotic Pharmaceuticals and who isolated...
Cambridge, UNITED STATES
Amy Spoering, Director of Biological Research at the biotech NovoBiotic Pharmaceuticals and who isolated...
Amy Spoering, Director of Biological Research at the biotech NovoBiotic Pharmaceuticals and who isolated from soil the bacterium Eleftheria terrae, the basis for the promising new antibiotic Teixobactin, holds a bag of dirt sent to the lab by a citizen-scientist at NovoBiotic's labs in Cambridge, Massachusetts, U.S., November 22, 2016. To match Special Report USA-UNCOUNTED/DRUGS REUTERS/Brian Snyder
USA-UNCOUNTED/DRUGS
RTX2V6RW
December 15, 2016
Krisha Menon, Chief Scientist and co-founder of biotechnology company Cellutix Corp, which is currently...
BEVERLY, UNITED STATES
Krisha Menon, Chief Scientist and co-founder of biotechnology company Cellutix Corp, which is currently...
Krisha Menon, Chief Scientist and co-founder of biotechnology company Cellutix Corp, which is currently developing the promising antibiotic Brilacidin, poses for a portrait in Cellutix's labs in Beverly, Massachusetts, U.S., November 22, 2016. To match Special Report USA-UNCOUNTED/DRUGS REUTERS/Brian Snyder
USA-UNCOUNTED/DRUGS
RTX2V6RV
December 15, 2016
A microscope shows the bacterium Eleftheria terrae, the basis for the promising new antibiotic Teixobactin,...
Cambridge, UNITED STATES
A microscope shows the bacterium Eleftheria terrae, the basis for the promising new antibiotic Teixobactin,...
A microscope shows the bacterium Eleftheria terrae, the basis for the promising new antibiotic Teixobactin, in NovoBiotic's labs in Cambridge, Massachusetts, U.S., November 22, 2016. To match Special Report USA-UNCOUNTED/DRUGS REUTERS/Brian Snyder
USA-UNCOUNTED/DRUGS
RTX2V6RQ
December 15, 2016
Slava Epstein, co-founder of NovBiotic, professor of biology at Northeastern University and co-inventor...
Cambridge, UNITED STATES
Slava Epstein, co-founder of NovBiotic, professor of biology at Northeastern University and co-inventor...
Slava Epstein, co-founder of NovBiotic, professor of biology at Northeastern University and co-inventor of an isolation chip to grow previously unculturable microorganisms, talks about the promising new antibiotic Teixobactin at NovoBiotic's labs in Cambridge, Massachusetts, U.S., November 22, 2016. To match Special Report USA-UNCOUNTED/DRUGS REUTERS/Brian Snyder
USA-UNCOUNTED/DRUGS
RTX2V6RO
December 15, 2016
Amy Spoering, Director of Biological Research at the biotech NovoBiotic Pharmaceuticals and who isolated...
Cambridge, UNITED STATES
Amy Spoering, Director of Biological Research at the biotech NovoBiotic Pharmaceuticals and who isolated...
Amy Spoering, Director of Biological Research at the biotech NovoBiotic Pharmaceuticals and who isolated from soil the bacterium Eleftheria terrae, the basis for the promising new antibiotic Teixobactin, holds bags of dirt sent to the lab by a citizen-scientist at NovoBiotic's labs in Cambridge, Massachusetts, U.S., November 22, 2016. To match Special Report USA-UNCOUNTED/DRUGS REUTERS/Brian Snyder
USA-UNCOUNTED/DRUGS
RTX2V6RM
December 15, 2016
Amy Spoering, Director of Biological Research at the biotech NovoBiotic Pharmaceuticals, holds up a sample...
Cambridge, UNITED STATES
Amy Spoering, Director of Biological Research at the biotech NovoBiotic Pharmaceuticals, holds up a sample...
Amy Spoering, Director of Biological Research at the biotech NovoBiotic Pharmaceuticals, holds up a sample of the bacterium Eleftheria terrae, the basis for the promising new antibiotic Teixobactin, at NovoBiotic's labs in Cambridge, Massachusetts, U.S., November 22, 2016. To match Special Report USA-UNCOUNTED/DRUGS REUTERS/Brian Snyder
USA-UNCOUNTED/DRUGS
RTX2V6RL
December 15, 2016
Dr. Kim Lewis, co-founder of biotechnology company NovoBiotic Pharmaceuticals, Director of Antimicrobial...
Boston, UNITED STATES
Dr. Kim Lewis holds up a test of new, potential antibiotics at his lab in Boston
Dr. Kim Lewis, co-founder of biotechnology company NovoBiotic Pharmaceuticals, Director of Antimicrobial Discovery Center at Northeastern University, and lead scientist on the team that discovered the promising new antibiotic Teixobactin being developed at NovoBiotic, holds up a test of new, potential antibiotics at his lab in Boston, Massachusetts, U.S., November 17, 2016. To match Special Report USA-UNCOUNTED/DRUGS REUTERS/Brian Snyder
USA-UNCOUNTED/DRUGS
RTX2V6RK
December 15, 2016
Dr. Kim Lewis, co-founder of biotechnology company NovoBiotic Pharmaceuticals, Director of Antimicrobial...
Boston, UNITED STATES
Dr. Kim Lewis holds one of the isolation chips he and colleague Slava Epstein invented to allow them...
Dr. Kim Lewis, co-founder of biotechnology company NovoBiotic Pharmaceuticals, Director of Antimicrobial Discovery Center at Northeastern University, and lead scientist on the team that discovered the promising new antibiotic Teixobactin being developed at NovoBiotic, holds one of the isolation chips he and colleague Slava Epstein invented to allow them to discover and cultivate previously unavailable bacterias at his office in Boston, Massachusetts, U.S., November 17, 2016. To match Special Report USA-UNCOUNTED/DRUGS REUTERS/Brian Snyder
USA-UNCOUNTED/DRUGS
RTX2V6RI
December 15, 2016
Kim Lewis, co-founder of biotechnology company NovoBiotic Pharmaceuticals, Director of Antimicrobial...
Boston, UNITED STATES
Kim Lewis, co-founder of biotechnology company NovoBiotic Pharmaceuticals, Director of Antimicrobial...
Kim Lewis, co-founder of biotechnology company NovoBiotic Pharmaceuticals, Director of Antimicrobial Discovery Center at Northeastern University, and lead scientist on the team that discovered the promising new antibiotic Teixobactin being developed at NovoBiotic, poses for a portrait at his office in Boston, Massachusetts, U.S., November 17, 2016. To match Special Report USA-UNCOUNTED/DRUGS REUTERS/Brian Snyder
USA-UNCOUNTED/DRUGS C
RTX2V6QW
December 15, 2016
Lethal bacteria are showing resistance to more and more antibiotics and financial and legal hurdles are...
UNITED STATES
Superbugs EPS C
Lethal bacteria are showing resistance to more and more antibiotics and financial and legal hurdles are making it harder than ever for science to create effective new drugs. Accompanies Reuters Special Report.
USA-UNCOUNTED/DRUGS C
RTX2V6QV
December 15, 2016
Lethal bacteria are showing resistance to more and more antibiotics and financial and legal hurdles are...
UNITED STATES
Superbugs EPS C
Lethal bacteria are showing resistance to more and more antibiotics and financial and legal hurdles are making it harder than ever for science to create effective new drugs. Accompanies Reuters Special Report.
USA-UNCOUNTED/DRUGS C
RTX2V6QT
December 15, 2016
Lethal bacteria are showing resistance to more and more antibiotics and financial and legal hurdles are...
UNITED STATES
Superbugs EPS C
Lethal bacteria are showing resistance to more and more antibiotics and financial and legal hurdles are making it harder than ever for science to create effective new drugs. Accompanies Reuters Special Report.
USA-UNCOUNTED/COSTS
RTX2UAEX
November 18, 2016
A rider passes the barns behind the house where Rae Greulich and her husband Dan, who died from an antibiotic...
AUGORA HILLS, UNITED STATES
A rider passes the barns behind the house where Rae Greulich and her husband Dan, who died from an antibiotic...
A rider passes the barns behind the house where Rae Greulich and her husband Dan, who died from an antibiotic resistant infection, once lived in Simi Valley, California, U.S. June 27, 2016. To match Special Report USA-UNCOUNTED/ REUTERS/David McNew
USA-UNCOUNTED/COSTS
RTX2UAEV
November 18, 2016
Rae Greulich, whose husband Dan died from an antibiotic resistant infection, reaches for one of her horses...
AUGORA HILLS, UNITED STATES
Rae Greulich, who's husband Dan died from an antibiotic resistant infection, reaches for one of her horses...
Rae Greulich, whose husband Dan died from an antibiotic resistant infection, reaches for one of her horses in Agoura Hills, California, U.S. June 27, 2016. To match Special Report USA-UNCOUNTED/ REUTERS/David McNew
USA-UNCOUNTED/COSTS
RTX2UAEU
November 18, 2016
Rae Greulich, whose husband Dan died from an antibiotic resistant infection, speaks to a reporter near...
AUGORA HILLS, UNITED STATES
Rae Greulich, whose husband Dan died from an antibiotic resistant infection, speaks to a reporter near...
Rae Greulich, whose husband Dan died from an antibiotic resistant infection, speaks to a reporter near a photo taken on their wedding day in Agoura Hills, California, U.S. June 27, 2016. To match Special Report USA-UNCOUNTED/ REUTERS/David McNew
Sort by
Display
Items per page
Page
of 6